Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico

Not Applicable

Completed

Interventions: Behavioral: Computerized brief intervention
Behavioral: Counselor delivered brief intervention

Brief Summary: The purpose of this study is to compare the effectiveness in reducing drug use and its associated problems of a brief intervention for drug use delivered by a behavioral health counselor as compared to a brief intervention delivered by a computerized intervention.

Detailed Description: Drug use is a significant cause of morbidity and mortality in the United States. Efforts to develop and rigorously evaluate methods to provide Screening, Brief Intervention and Referral to Treatment (SBIRT) for drug users are needed. Computerized screening and brief interventions in particular have the potential to circumvent some of the potential problems of integrating SBIRT delivered by a counselor into busy primary care settings. These interventions may reduce drug use among individuals who are using drugs but are not yet drug dependent.

Recruitment & Eligibility

Inclusion Criteria

Exclusion Criteria

planning to move out of New Mexico in the next year
receipt of formal drug abuse treatment or a brief intervention for drug use in the past month.

Arm && Interventions

Group	Intervention	Description
Computerized Brief Intervention	Computerized brief intervention	Computerized one-session brief intervention for drug use
Counselor delivered brief intervention	Counselor delivered brief intervention	This is a brief intervention focused on drug use delivered by a behavioral health counselor and based on motivational interviewing

Primary Outcome Measures

Name	Time	Method
Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score	3 months post-baseline	The ASSIST's Global Continuum of Illicit Drug Risk was used. A higher score is considered more severe risk. The scores range from 0 to 308.
Hair Testing	3 month post-baseline	The number of participants testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC)

Secondary Outcome Measures

Name	Time	Method
Human Immunodeficiency Virus (HIV) Drug Use Risk Assessment Battery Subscale	3 months post-baseline	HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.
Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score	12 months post-baseline	ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.
Hair Testing	12 month post-baseline	Predicted Probabilities for testing positive on the Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and THC, calculated from generalized estimating equations.
Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale	6 month post-baseline	HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.
Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale Score	12 month post-baseline	HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.